Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS/MS
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 87, 79-84
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 26 references indexed in Scilit:
- High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identifiedClinica Chimica Acta, 2020
- Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher DiseaseInternational Journal of Molecular Sciences, 2019
- Clinical and molecular characteristics of patients with Gaucher disease in Southern ChinaBlood Cells, Molecules, and Diseases, 2018
- Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher diseaseScientific Reports, 2018
- Successful newborn screening for Gaucher disease using fluorometric assay in ChinaJournal of Human Genetics, 2017
- A Review of Gaucher Disease Pathophysiology, Clinical Presentation and TreatmentsInternational Journal of Molecular Sciences, 2017
- Gaucher disease epidemiology and natural history: a comprehensive review of the literatureHematology, 2016
- Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease PatientsPLOS ONE, 2013
- Multi-system disorders of glycosphingolipid and ganglioside metabolismJournal of Lipid Research, 2010
- The Gaucher RegistryArchives of internal medicine (1960), 2000